Albert, C.
Bracaglia, L.
Koide, A.
DiRito, J.
Lysyy, T. http://orcid.org/0000-0002-6210-7407
Harkins, L.
Edwards, C.
Richfield, O.
Grundler, J. http://orcid.org/0000-0003-4848-713X
Zhou, K.
Denbaum, E.
Ketavarapu, G. http://orcid.org/0000-0001-5029-8595
Hattori, T.
Perincheri, S.
Langford, J.
Feizi, A. http://orcid.org/0000-0001-6960-7028
Haakinson, D.
Hosgood, S. A.
Nicholson, M. L.
Pober, J. S.
Saltzman, W. M. http://orcid.org/0000-0002-2163-549X
Koide, S. http://orcid.org/0000-0001-5473-4358
Tietjen, G. T. http://orcid.org/0000-0002-7227-2887
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI132895, AI145965)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | NCI | Division of Cancer Epidemiology and Genetics, National Cancer Institute (CA194864)
American Association for the Study of Liver Diseases
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (HL157552)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK007276)
Article History
Received: 12 June 2021
Accepted: 20 September 2022
First Online: 11 October 2022
Competing interests
: A.K. and S.K. are listed as inventors on issued and pending patents on the monobody technology filed by the University of Chicago and Novartis AG (US Patent 9512199 B2 and related pending applications). G.T., S.K., W.M.S, C.A., J.S.P., A.K., and L.G.B. are listed as inventors on pending patent using the Mb adapter to build targeted NPs filed by Yale University and New York University (US Patent 20210206879 A1). G.T.T., S.K., and J.D. are co-founders and equity stake holders in Revalia Bio Inc. S.K. was a SAB member and held equity in and received consulting fees from Black Diamond Therapeutics, and has received research support from Argenx BVBA, Black Diamond Therapeutics and Puretech Health. The remaining authors declare no competing interests.